Efficacy of Early Administration of Tocilizumab in COVID-19 Patients
Status:
Terminated
Trial end date:
2020-06-06
Target enrollment:
Participant gender:
Summary
The clinical study aims at assessing whether early administration of Tocilizumab compared to
late administration of Tocilizumab can reduce the number of patients with COVID-19 pneumonia
who require mechanical ventilation. The clinical study includes patients with recent-onset
COVID-19 pneumonia who require hospital care, but not invasive or semi-invasive mechanical
ventilation procedures.